GABA — Gabather AB Share News
0.000.00%
- SEK14.41m
- SEK10.72m
Brief: Gabather Carries Out Rights Issue Of Units Of About SEK 28.6 Mln
Brief: Gabather Q3 Operating Loss Widens To SEK 2.8 Mln
Brief: Gabather Q2 Operating Loss Narrows To SEK 1.6 Million
Brief: Gabather Q1 Oper Loss Stable At SEK 2.0 Million
Brief: Gabather Receives Notice Of Approval From Japanese Patent Office
Brief: Gabather Raises SEK 4.0 Mln In Rights Issue Proceeds
Brief: Gabather Reports Positive Preliminary Results From Ongoing Clinical Study
Brief: Gabather Rights Issue Of Maximum Of 3,406,822 Shares
Brief: Gabather Q3 Operating Loss Narrows To SEK 2.1 Million
Brief: Gabather Q2 Operating Loss Narrows To SEK 2.1 Mln
Brief: Gabather Q4 Operating Loss Widens To SEK 5.3 Mln
Brief: Gabather Q3 Operating Loss Narrows To SEK 3.8 Mln
Brief: Gabather Carries Out Fully Subscribed To Rights Issue Of Units Of Sek 18 Million
Brief: Gabather Q2 Operating Loss Widens To SEK 4.2 Mln
Brief: Gabather AB - Announces Outcome In Arbitration With Smerud Medical Research As
Brief: Gabather AB - Q1 Operating Expenses Amounted To Sek 3,456 Thousand
Brief: Gabather Starts Cooperation With Leading Researchers In USA
Brief: Gabather Q4 Operating Loss Narrows To Sek 3.4 Million
Brief: Gabather Appoints New CFO